1. Sir Bruce Keogh. Poly Implant Prostheses (PIP) Breast Implants: Interim Report of the Expert Group: Department of Health 6 January 2012.
  2. SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). Safety of PIP Silicone Breast Implant. 1 February 2012.
  3. Therapeutic Goods Administration. Information regarding tests that have been conducted on silicone gel filled breast implants manufactured by Poly-Implant Prothese (PIP). 2012 [updated 12 January 2012]; Available from: http://www.tga.gov.au/newsroom/media-2012-breast-implants-120112.htm.
  4. AFSSAPS. Record of Checks Carried Out by the Health Authorities on the Company Poly Implant Prothese (PIP). Paris 2012 February 1 2012.
  5. Press release available at http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON137935.
  6. Cancer Australia. Breast Cancer Risk Factors: a review of the evidence.
  7. Lipworth L, Tarone RE, Friis S, Ye W, Olsen JH, Nyren O, et al. Cancer among Scandivanian women with cosmetic breast implants: a pooled long-term follow up study. Int J Cancer. 2009;124(2):490-3.
  8. Friis S, Holmich LR, McLaughlin JK, Kjoller K, Fryzek JP, Henriksen TF, et al. Cancer risk among Danish women with cosmetic breast implants. Int J Cancer. 2006 Feb 15;118(4):998-1003.
  9. McLaughlin JK, Lipworth L, Fryzek JP, Ye W, Tarone RE, Nyren O. Long-Term Cancer Risk Among Swedish Women With Cosmetic Breast Implants: An Update of a Nationwide Study. Journal of the National Cancer Institute. 2006 19 April 2006;98(8):557-60.
  10. Brisson J, Holowaty EJ, Villeneuve P, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer. 2006;118:2854-62.
  11. National Cancer Institute (INCA). Proposed measures to be taken for women with PIP breast implants: Experts' opinion. 22 December 2011.
  12. US Food and Drug Administration. Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants: Preliminary FDA Findings and Analyses: FDAJanuary 2011.
  13. Kim B, Roth C, Chung KC, Young VL, van Busum K, Schnyer C, et al. Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg. 2011 Jun;127(6):2141-50.
  14. Therapeutic Goods Administration. PIP breast implants - an updated Australian perspective. 2012 [cited 2012 April 13]; Available from: http://www.tga.gov.au/safety/alerts-device-breast-implants-pip-120323.htm.
  15. Center for Devices and Radiological Health F. FDA Update on the Safety of Silicone Gel-Filled Breast Implants. June 2011.
  16. Hölmich LR, Friis S, Fryzek JP, Vejborg IM, Conrad C, Sletting S, et al. Incidence of silicone breast implant rupture. Arch Surg. 2003 Jul;138(7):801-6.
  17. Brown SL, Middleton MS, Berg WA, Soo MS, Pennello G. Prevalence of Rupture of Silicone Gel Breast Implants Revealed on MR Imaging in a Population of Women in Birmingham, Alabama. American Journal of Roentgenology. 2000 October 1, 2000;175(4):1057-64.
  18. Gorczyca DP, Gorczyca SM, Gorczyca KL. The diagnosis of silicone breast implant rupture. Plast Reconstr Surg. 2007 Dec;120(7 Suppl 1):49S-61S.
  19. Song JW, Kim HM, Bellfi LT, Chung KC. The effect of study design biases on the diagnostic accuracy of magnetic resonance imaging for detecting silicone breast implant ruptures: a meta-analysis. Plast Reconstr Surg. 2011 Mar;127(3):1029-44.
  20. US Food and Drug Administration. Breast implants: Local complications and adverse outcomes.
  21. Adams ST, Cox J, Rao GS. Axillary silicone lymphadenopathy presenting with a lump and altered sensation in the breast: a case report. J Med Case Reports. 2009;3(6442):6442.
  22. Malyon AD, Dunn R, Weiler-Mithoff EM. Expanding silicone granuloma. Br J Plast Surg. 2001 Apr;54(3):257-9.
  23. Hölmich LR, Vejborg IM, Conrad C, Sletting S, Høier-Madsen M, Fryzek JP, et al. Untreated silicone breast implant rupture. Plast Reconstr Surg. 2004 Jul;114(1):204-14; discussion 15-6.
  24. Cawrse NH, Pickford MA. Cutaneous manifestation of silicone dissemination from a PIP implant - a case for prophylactic explantation? Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2011;64(8):e208-e9.
  25. Choi JJ, Lee JH, Kang BJ, Kim SH, Ahn ST, Yoon WJ, et al. Clinical and imaging characteristics of Polyimplant Prosthesis hydrogel breast implants. J Comput Assist Tomogr. 2010 May-Jun;34(3):449-55.
  26. Lahiri A, Waters R. Locoregional silicone spread after high cohesive gel silicone implant rupture. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2006;59(8):885-6.
  27. Australian and New Zealand College of Anaesthetists. Risks and Complications (of anaesthesia). Available from: http://www.anzca.edu.au/patients/frequently-asked-questions/risks-and-complications.html/?searchterm=risks%20of%20surgery.
  28. Henriksen TF, Fryzek JP, Holmich LR, McLaughlin JK, Krag C, Karlsen R, et al. Reconstructive breast implantation after mastectomy for breast cancer: clinical outcomes in a nationwide prospective cohort study. Arch Surg. 2005 Dec;140(12):1152-9; discussion 60-1.
  29. Spear SL, Murphy DK, Slicton A, Walker PS. Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007 Dec;120(7 Suppl 1):8S-16S; discussion 7S-8S.
  30. Handel N, Cordray T, Gutierrez J, Jensen JA. A long-term study of outcomes, complications, and patient satisfaction with breast implants. Plast Reconstr Surg. 2006 Mar;117(3):757-67; discussion 68-72.
  31. Poly Implant Prothese (PIP) breast implants: Joint surgical statement on clinical guidance for patients, GPs and surgeonsJanuary 2012.

Top of page